Acceleron  

Publications

  • Publication
    Dalantercept
    Jun 30, 2011
    ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011; 117(26): 6999-7006
    + VIEW FULL Publication
  • Publication
    ACE-031
    May 1, 2011
    Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse. Muscle & Nerve 2011; 43(5): 694-9
    + VIEW FULL Publication
  • Publication
    ACE-031
    Mar 1, 2011
    Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy. Am J Pathol 2011;178(3):1287-97
    + VIEW FULL Publication